Cognition Therapeutics Inc (CGTX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

72.77M
Year ended 2025-12-31
+45.5%
3-year compound annual growth
2020-12-31: 508.1K2021-12-31: 5.19M2022-12-31: 23.64M2023-12-31: 30.03M2024-12-31: 39.73M2025-12-31: 72.77M72.77M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3172.77M+83.2%2026-03-26, From 2025-01-01
2024-12-3139.73M+32.3%2026-03-26, From 2024-01-01
2023-12-3130.03M+27.0%2025-03-20, From 2023-01-01
2022-12-3123.64M+355.4%2024-03-26, From 2022-01-01
2021-12-315.19Mn/c2023-03-23, From 2021-01-01
2020-12-31508.1Kn/a2022-03-30, From 2020-01-01